Foreword

Over the past year, attention has turned to the pharmaceutical patent cliff, with a range of companies adapting to – or preparing for – the post-patent commercial reality. In such an environment, branding and trademark rights play a critical role in guarding and extending market share. Yet establishing and protecting those brands is a complex process – strict controls at both the national and international levels mean that rights holders and their advisers must have detailed knowledge of the regulatory regimes that exist in parallel to the standard registration systems. To assist counsel in this competitive market, World Trademark Review is pleased to present the fourth edition of Pharmaceutical Trademarks – A Global Guide.